Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Peri

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|June 23, 2009
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D)Alessandro Palmioli, Elena Sacco, Cristina Airoldi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 30, 2014
Chemistry of lipid A: at the heart of innate immunityAntonio Molinaro, Otto Holst, Flaviana Di Lorenzo, et al.
Journal of Medicinal Chemistry|May 17, 2022
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart FailureAndrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Frontiers in Molecular Biosciences|March 8, 2021
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer CellsRenata Tisi, Michela Spinelli, Alessandro Palmioli, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Journal of Medicinal Chemistry|October 1, 2014
Trehalose- and glucose-derived glycoamphiphiles: small-molecule and nanoparticle Toll-like receptor 4 (TLR4) modulatorsJulio Rodriguez Lavado, Stefania E Sestito, Roberto Cighetti, et al.
The FEBS Journal|July 20, 2007
Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptorsEstuardo López-Vera, Manuel B Aguilar, Emanuele Schiavon, et al.
Journal of Medicinal Chemistry|August 12, 2021
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo ActivityFabio A Facchini, Alberto Minotti, Andrea Luraghi, et al.
Vascular Pharmacology|July 10, 2024
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatmentMartina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Medicinal Chemistry|March 2, 2018
Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) AntagonistsFabio A Facchini, Lenny Zaffaroni, Alberto Minotti, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|June 23, 2009
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D)Alessandro Palmioli, Elena Sacco, Cristina Airoldi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 30, 2014
Chemistry of lipid A: at the heart of innate immunityAntonio Molinaro, Otto Holst, Flaviana Di Lorenzo, et al.
Journal of Medicinal Chemistry|May 17, 2022
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart FailureAndrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Frontiers in Molecular Biosciences|March 8, 2021
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer CellsRenata Tisi, Michela Spinelli, Alessandro Palmioli, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Journal of Medicinal Chemistry|October 1, 2014
Trehalose- and glucose-derived glycoamphiphiles: small-molecule and nanoparticle Toll-like receptor 4 (TLR4) modulatorsJulio Rodriguez Lavado, Stefania E Sestito, Roberto Cighetti, et al.
The FEBS Journal|July 20, 2007
Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptorsEstuardo López-Vera, Manuel B Aguilar, Emanuele Schiavon, et al.
Journal of Medicinal Chemistry|August 12, 2021
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo ActivityFabio A Facchini, Alberto Minotti, Andrea Luraghi, et al.
Vascular Pharmacology|July 10, 2024
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatmentMartina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Medicinal Chemistry|March 2, 2018
Structure-Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) AntagonistsFabio A Facchini, Lenny Zaffaroni, Alberto Minotti, et al.
Pageof 10